Our second point of inquiry concerned the axonal neurodegeneration detected in some patients with neural antibody-associated dementia (2, 8–11) to see if tau pathology is associated with rapidly worsening cognitive impairment in both dementia types. This evidence concerns the gene MAPT and Cognitive impairment.